Indications
Treatment of Alzheimer’s disease and dementia.
Composition
- Active substance
- blarcamesine hydrochloride
- International name (INN)
- blarcamesine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Blarcamesine Anavex
- Active substance
- blarcamesine hydrochloride
- ATC code
- N06D
- Group
- Nervous system
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/006475